MAPT and Alzheimer disease: Furthermore, clinical evidence implicates ApoE4’s interaction with Aβ is related to increased Tau deposition in AD vulnerable regions in the brain (Therriault et al., 2021), which mirrors the importance of Aβ in the acceleration of AD Tau dynamics (Lee et al., 2022).